Evidence map›Paper›PMID 34837653›Full record

ArticleWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society2022

The lysosomal trafficking regulator is necessary for normal wound healing.

Jacob C Zbinden, Gabriel J M Mirhaidari, Kevin M Blum, Andrew J Musgrave, James W Reinhardt, Christopher K Breuer, Jenny C Barker

Open access · greenAbstract read
In one paragraph

Article in Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Chedíak-Higashi Syndrome: Hair-to-toe spectrum.Seminars in pediatric neurology · 2024
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jacob C ZbindenCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID 0000-0002-0262-383X
Gabriel J M MirhaidariCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Kevin M BlumCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Andrew J MusgraveCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
James W ReinhardtCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Christopher K BreuerCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Jenny C BarkerCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Nationwide Children's Hospital · US

Funding

Advanced Research Training in Immunology for Surgery Trainees (ARTIST)T32AI106704 · NIAID · OHIO STATE UNIVERSITY · PI GINNY L BUMGARDNER, Jon R Wisler · 2014 to 2026
$3.5M
Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft StenosisR01HL157491 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BREUER, CHRISTOPHER KANE · 2021 to 2024
$2.9M
Development of an Improved Vascular Graft for Use in Congenital Heart SurgeryR01HL128847 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BREUER, CHRISTOPHER KANE · 2016 to 2019
$2.8M
Development of a LystaMab coated pericardial adhesion barrierR43HL152844 · NHLBI · LYST THERAPEUTICS, LLC · PI BEST, CAMERON AUSTIN, BREUER, CHRISTOPHER KANE · 2020 to 2020
$309k
LystaMab Immunotherapy to Inhibit Pericardial AdhesionsR41HL145827 · NHLBI · LYST THERAPEUTICS, LLC · PI BREUER, CHRISTOPHER KANE · 2019 to 2019
$225k
Modulating the Host Response to Tissue Engineered Vascular GraftsF32HL144120 · NHLBI · OHIO STATE UNIVERSITY · PI BARKER, JENNY CATHRYN · 2019 to 2021
$103k
NHLBI NIH HHS F32 HL144120NHLBI NIH HHS R01 HL128847NHLBI NIH HHS R01 HL157491NHLBI NIH HHS R41 HL145827NHLBI NIH HHS R43 HL152844NIAID NIH HHS T32 AI106704
6 · The paper itself

Abstract

Non-healing wounds are a major threat to public health throughout the United States. Tissue healing is complex multifactorial process that requires synchronicity of several cell types. Endolysosomal trafficking, which contributes to various cell functions from protein degradation to plasma membrane repair, is an understudied process in the context of wound healing. The lysosomal trafficking regulator protein (LYST) is an essential protein of the endolysosomal system through an indeterminate mechanism. In this study, we examine the impact of impaired LYST function both in vitro with primary LYST mutant fibroblasts as well as in vivo with an excisional wound model. The wound model shows that LYST mutant mice have impaired wound healing in the form of delayed epithelialization and collagen deposition, independent of macrophage infiltration and polarisation. We show that LYST mutation confers a deficit in MCP-1, IGF-1, and IGFBP-2 secretion in beige fibroblasts, which are critical factors in normal wound healing. Identifying the mechanism of LYST function is important for understanding normal wound biology, which may facilitate the development of strategies to address problem wound healing.

Indexed as

LysosomesWound HealingAnimalsCollagenFibroblastsMiceRe-EpithelializationCollagenepithelializationIGF-1IGFBP-2lysosomal trafficking regulatorLYSTMCP-1wound healing

Identifiers

PMID34837653
PMCPMC9004365
OpenAlexW3216853654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.